These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35546239)

  • 1. Immunogenomic intertumor heterogeneity across primary and metastatic sites in a patient with lung adenocarcinoma.
    Chen R; Li J; Fujimoto J; Hong L; Hu X; Quek K; Tang M; Mitra A; Behrens C; Chow CW; Jiang P; Little LD; Gumbs C; Song X; Zhang J; Tan D; Heymach JV; Wistuba I; Futreal PA; Gibbons DL; Byers LA; Zhang J; Reuben A
    J Exp Clin Cancer Res; 2022 May; 41(1):172. PubMed ID: 35546239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TCR Repertoire Intratumor Heterogeneity in Localized Lung Adenocarcinomas: An Association with Predicted Neoantigen Heterogeneity and Postsurgical Recurrence.
    Reuben A; Gittelman R; Gao J; Zhang J; Yusko EC; Wu CJ; Emerson R; Zhang J; Tipton C; Li J; Quek K; Gopalakrishnan V; Chen R; Vence LM; Cascone T; Vignali M; Fujimoto J; Rodriguez-Canales J; Parra ER; Little LD; Gumbs C; Forget MA; Federico L; Haymaker C; Behrens C; Benzeno S; Bernatchez C; Sepesi B; Gibbons DL; Wargo JA; William WN; Swisher S; Heymach JV; Robins H; Lee JJ; Sharma P; Allison JP; Futreal PA; Wistuba II; Zhang J
    Cancer Discov; 2017 Oct; 7(10):1088-1097. PubMed ID: 28733428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic Genomics and Clinical Features of Lung Adenocarcinoma: A Retrospective Study.
    Shi J; Hua X; Zhu B; Ravichandran S; Wang M; Nguyen C; Brodie SA; Palleschi A; Alloisio M; Pariscenti G; Jones K; Zhou W; Bouk AJ; Boland J; Hicks B; Risch A; Bennett H; Luke BT; Song L; Duan J; Liu P; Kohno T; Chen Q; Meerzaman D; Marconett C; Laird-Offringa I; Mills I; Caporaso NE; Gail MH; Pesatori AC; Consonni D; Bertazzi PA; Chanock SJ; Landi MT
    PLoS Med; 2016 Dec; 13(12):e1002162. PubMed ID: 27923066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic Landscape and Immune Microenvironment Features of Preinvasive and Early Invasive Lung Adenocarcinoma.
    Zhang C; Zhang J; Xu FP; Wang YG; Xie Z; Su J; Dong S; Nie Q; Shao Y; Zhou Q; Yang JJ; Yang XN; Zhang XC; Li Z; Wu YL; Zhong WZ
    J Thorac Oncol; 2019 Nov; 14(11):1912-1923. PubMed ID: 31446140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneous immunogenomic features and distinct escape mechanisms in multifocal hepatocellular carcinoma.
    Dong LQ; Peng LH; Ma LJ; Liu DB; Zhang S; Luo SZ; Rao JH; Zhu HW; Yang SX; Xi SJ; Chen M; Xie FF; Li FQ; Li WH; Ye C; Lin LY; Wang YJ; Wang XY; Gao DM; Zhou H; Yang HM; Wang J; Zhu SD; Wang XD; Cao Y; Zhou J; Fan J; Wu K; Gao Q
    J Hepatol; 2020 May; 72(5):896-908. PubMed ID: 31887370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the spatiotemporal genetic heterogeneity in metastatic lung adenocarcinoma using a nuclei flow-sorting approach.
    Lorber T; Andor N; Dietsche T; Perrina V; Juskevicius D; Pereira K; Greer SU; Krause A; Müller DC; Savic Prince S; Lardinois D; Barrett MT; Ruiz C; Bubendorf L
    J Pathol; 2019 Feb; 247(2):199-213. PubMed ID: 30350422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic profiles and their associations with TMB, PD-L1 expression, and immune cell infiltration landscapes in synchronous multiple primary lung cancers.
    Hu C; Zhao L; Liu W; Fan S; Liu J; Liu Y; Liu X; Shu L; Liu X; Liu P; Deng C; Qiu Z; Chen C; Jiang Y; Liang Q; Yang L; Shao Y; He Q; Yu D; Zeng Y; Li Y; Pan Y; Zhang S; Shi S; Peng Y; Wu F
    J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34887263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic Alterations in Preinvasive Lung Synchronous Lesions.
    Ahn S; Lim J; Park SY; Kim H; Kwon HJ; Han YB; Lee CT; Cho S; Chung JH
    Cancer Res Treat; 2020 Oct; 52(4):1120-1134. PubMed ID: 32599981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic profiles and transcriptomic microenvironments in 2 patients with synchronous lung adenocarcinoma and lung squamous cell carcinoma: a case report.
    Wu L; Kang P; Tao S; Zhao Z; Chen L; Xiao Y; Tan Q
    BMC Med Genomics; 2020 Jan; 13(1):15. PubMed ID: 32005243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global DNA methylation reflects spatial heterogeneity and molecular evolution of lung adenocarcinomas.
    Dietz S; Lifshitz A; Kazdal D; Harms A; Endris V; Winter H; Stenzinger A; Warth A; Sill M; Tanay A; Sültmann H
    Int J Cancer; 2019 Mar; 144(5):1061-1072. PubMed ID: 30350867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphological and genetic heterogeneity in multifocal lung adenocarcinoma: The case of a never-smoker woman.
    Bonanno L; Calabrese F; Nardo G; Calistri D; Tebaldi M; Tedaldi G; Polo V; Vuljan S; Favaretto A; Conte P; Amadori A; Rea F; Indraccolo S
    Lung Cancer; 2016 Jun; 96():52-5. PubMed ID: 27133750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of genomic and immune intratumor heterogeneity in linitis plastica via multiregional exome and T-cell receptor sequencing.
    Huang J; Zhao G; Peng Q; Yi X; Ji L; Li J; Li P; Guan Y; Ge J; Chen L; Chen R; Hu X; Lee WC; Reuben A; Futreal PA; Xia X; Ma J; Zhang J; Chen Z
    Mol Oncol; 2023 Aug; 17(8):1531-1544. PubMed ID: 36703611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiomics profiling of primary lung cancers and distant metastases reveals immunosuppression as a common characteristic of tumor cells with metastatic plasticity.
    Lee WC; Reuben A; Hu X; McGranahan N; Chen R; Jalali A; Negrao MV; Hubert SM; Tang C; Wu CC; Lucas AS; Roh W; Suda K; Kim J; Tan AC; Peng DH; Lu W; Tang X; Chow CW; Fujimoto J; Behrens C; Kalhor N; Fukumura K; Coyle M; Thornton R; Gumbs C; Li J; Wu CJ; Little L; Roarty E; Song X; Lee JJ; Sulman EP; Rao G; Swisher S; Diao L; Wang J; Heymach JV; Huse JT; Scheet P; Wistuba II; Gibbons DL; Futreal PA; Zhang J; Gomez D; Zhang J
    Genome Biol; 2020 Nov; 21(1):271. PubMed ID: 33148332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KEAP1-driven co-mutations in lung adenocarcinoma unresponsive to immunotherapy despite high tumor mutational burden.
    Marinelli D; Mazzotta M; Scalera S; Terrenato I; Sperati F; D'Ambrosio L; Pallocca M; Corleone G; Krasniqi E; Pizzuti L; Barba M; Carpano S; Vici P; Filetti M; Giusti R; Vecchione A; Occhipinti M; Gelibter A; Botticelli A; De Nicola F; Ciuffreda L; Goeman F; Gallo E; Visca P; Pescarmona E; Fanciulli M; De Maria R; Marchetti P; Ciliberto G; Maugeri-Saccà M
    Ann Oncol; 2020 Dec; 31(12):1746-1754. PubMed ID: 32866624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EGFR mutation heterogeneity and the mixed response to EGFR tyrosine kinase inhibitors of lung adenocarcinomas.
    Chen ZY; Zhong WZ; Zhang XC; Su J; Yang XN; Chen ZH; Yang JJ; Zhou Q; Yan HH; An SJ; Chen HJ; Jiang BY; Mok TS; Wu YL
    Oncologist; 2012; 17(7):978-85. PubMed ID: 22673630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA Methylation Profiling Identifies Subgroups of Lung Adenocarcinoma with Distinct Immune Cell Composition, DNA Methylation Age, and Clinical Outcome.
    Guidry K; Vasudevaraja V; Labbe K; Mohamed H; Serrano J; Guidry BW; DeLorenzo M; Zhang H; Deng J; Sahu S; Almonte C; Moreira AL; Tsirigos A; Papagiannakopoulos T; Pass H; Snuderl M; Wong KK
    Clin Cancer Res; 2022 Sep; 28(17):3824-3835. PubMed ID: 35802677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up.
    Kadara H; Choi M; Zhang J; Parra ER; Rodriguez-Canales J; Gaffney SG; Zhao Z; Behrens C; Fujimoto J; Chow C; Yoo Y; Kalhor N; Moran C; Rimm D; Swisher S; Gibbons DL; Heymach J; Kaftan E; Townsend JP; Lynch TJ; Schlessinger J; Lee J; Lifton RP; Wistuba II; Herbst RS
    Ann Oncol; 2017 Jan; 28(1):75-82. PubMed ID: 27687306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Multiple synchronous lung adenocarcinoma: Interest of molecular biology for staging].
    Boukhiar S; Tiffet O; Bayle-Bleuez S; Picot T; Yvorel V; Forest F
    Rev Mal Respir; 2021 Nov; 38(9):942-945. PubMed ID: 34565641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of Genomic and T-cell Repertoire Heterogeneity of Malignant Pleural Mesothelioma Under Dasatinib Treatment.
    Chen R; Lee WC; Fujimoto J; Li J; Hu X; Mehran R; Rice D; Swisher SG; Sepesi B; Tran HT; Chow CW; Little LD; Gumbs C; Haymaker C; Heymach JV; Wistuba II; Lee JJ; Futreal PA; Zhang J; Reuben A; Tsao AS; Zhang J
    Clin Cancer Res; 2020 Oct; 26(20):5477-5486. PubMed ID: 32816946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole exome sequencing of lung adenocarcinoma and lung squamous cell carcinoma in one individual: A case report.
    Bai Y; Xu Y; Wang X; Liu Y; Sun C; Guo Y; Cai Y; Shao G; Yang Z; Qiu S; Ma K
    Thorac Cancer; 2020 Aug; 11(8):2361-2364. PubMed ID: 32578383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.